Ronald Blasberg at Memorial Sloan-Kettering Cancer Center, Imaging of gene expression; Harvey Herschman at U. California, Los Angeles, Tracking of gene therapy, gene activities; David Piwnica-Worms at ...
In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to Ron Heeren, a speaker at the 2023 James L. Waters Symposium. Please could you introduce yourself, and tell us ...
Siemens Medical Solutions is one of several imaging companies that have jumped into the world of molecular imaging, with a particular focus on systems and biomarkers that work with the brain and ...
About Molecular Imaging Molecular imaging allows clinicians to visualize and quantify biological processes at the molecular and cellular level in real time, enabling earlier disease detection and ...
A new strategy that combines two types of PET scans can guide personalized radiotherapy for head and neck cancers, according ...
The Case Comprehensive Cancer Center will host its next seminar series event Friday, Feb. 2, from noon to 1 p.m. in the Iris S. and Bert L. Wolstein Research Building auditorium. The event will ...
Radiopharmaceutical therapy and molecular imaging—together known as Theranostics—are gaining significant traction worldwide. Even though Theranostics dates back to the early 1940s, a rapid expansion ...
A new fluorescent imaging probe can for the first time objectively and non-invasively measure loss of smell, clinically known as anosmia. Targeting the olfactory nerve, the new tool has potential to ...
NEW ORLEANS (June 23, 2025)—The Society of Nuclear Medicine and Molecular Imaging (SNMMI) recognized seven new Fellows today during a plenary session at the society’s 2025 Annual Meeting, held June 21 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results